Verloes–Van Maldergem–Marneffe syndrome
Verloes–Van Maldergem–Marneffe syndrome is a rare genetic disorder characterized by a range of physical and developmental anomalies. This syndrome is named after the researchers who first described it, highlighting its rarity and the collaborative effort in its identification. The condition is part of a broader category of genetic disorders, which are caused by changes to the DNA sequence. Verloes–Van Maldergem–Marneffe syndrome is notable for its complex presentation, which can vary significantly among affected individuals.
Symptoms and Characteristics[edit | edit source]
The syndrome is marked by a constellation of symptoms, including but not limited to, intellectual disability, distinctive facial features, and skeletal abnormalities. Patients may also exhibit growth delays, both prenatally and postnatally. The facial features characteristic of Verloes–Van Maldergem–Marneffe syndrome include a prominent forehead, widely spaced eyes (hypertelorism), a broad nasal bridge, and a small chin (micrognathia). Skeletal anomalies might include scoliosis (curvature of the spine), joint hypermobility, and abnormalities in the hands and feet.
Genetics[edit | edit source]
Verloes–Van Maldergem–Marneffe syndrome is believed to be inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the syndrome. The specific genes involved in this syndrome have not been definitively identified, reflecting the complexity of genetic research in rare disorders. Genetic counseling is recommended for families with a history of the syndrome, as it can provide information on the risk of recurrence in future pregnancies.
Diagnosis[edit | edit source]
Diagnosis of Verloes–Van Maldergem–Marneffe syndrome is primarily based on clinical evaluation and the identification of characteristic symptoms. Genetic testing may aid in the diagnosis, although the absence of a clearly identified genetic marker can complicate this process. Early diagnosis is crucial for the management of symptoms and the provision of appropriate care and support to affected individuals and their families.
Management and Treatment[edit | edit source]
There is no cure for Verloes–Van Maldergem–Marneffe syndrome, and treatment is symptomatic and supportive. Management strategies may include physical therapy, special education programs, and surgical interventions to address specific anomalies. A multidisciplinary approach is often necessary to address the wide range of symptoms associated with the syndrome.
Prognosis[edit | edit source]
The prognosis for individuals with Verloes–Van Maldergem–Marneffe syndrome varies depending on the severity of symptoms and the presence of associated health issues. With appropriate care and support, many individuals with the syndrome can lead fulfilling lives.
See Also[edit | edit source]
Verloes–Van Maldergem–Marneffe syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD